Search for: "USA v. Andrew Williams" Results 1 - 20 of 117
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 Jul 2013, 9:26 pm by Patent Docs
This principle of patent law was reaffirmed by the Federal Circuit last week in Teva Pharmaceuticals USA, Inc. v. [read post]
26 Sep 2013, 9:33 pm by Patent Docs
By Andrew Williams -- Saying "But I won't do it" is not sufficient to avoid infringement in a Hatch-Waxman litigation, according to the Federal Circuit in the recently decided Sunovion Pharmaceuticals, Inc. v. [read post]
14 Oct 2014, 9:59 pm by Patent Docs
By Andrew Williams -- On Wednesday, the Supreme Court will hear oral arguments in the Teva Pharmaceuticals USA, Inc. v. [read post]
9 Oct 2014, 9:59 pm by Patent Docs
By Andrew Williams -- Next week, the Supreme Court will hear oral arguments in the Teva Pharmaceuticals USA, Inc. v. [read post]
31 Mar 2014, 8:47 pm by Patent Docs
By Andrew Williams -- Earlier today, the Supreme Court granted certiorari in the Teva Pharmaceuticals USA, Inc. v. [read post]
25 Jun 2015, 9:48 pm by Patent Docs
By Andrew Williams -- On June 18, 2015, the Federal Circuit handed down its second opinion in the Teva Pharmaceuticals USA v. [read post]
6 Feb 2014, 9:59 pm by Patent Docs
By Andrew Williams -- The standard of review at the Federal Circuit is important. [read post]
15 May 2018, 9:19 pm by Patent Docs
By Andrew Williams -- Since the Supreme Court's decision in TC Heartland LLC v. [read post]
17 May 2009, 9:55 pm
By Andrew Williams -- Last Thursday, the Federal Circuit affirmed the decision of the District Court for the District of New Jersey denying a request by Altana Pharma and Wyeth (collectively "Altana") for a preliminary injunction to prevent Teva Pharmaceuticals ("Teva") from marketing a generic version of the antiulcer drug Protonix ®. [read post]
18 Nov 2013, 9:59 pm by Patent Docs
By Andrew Williams -- Last week, the Patent Trial and Appeal Board ("PTAB" or "Board") issued the first inter partes review opinion in case IPR2012-00001, Garmin USA, Inc. [read post]
., Ltd. and HEC Pharm USA Inc., vacated its prior decision, and reversed the district court’s judgment that the claims of patent at issue were not invalid (Novartis Pharmaceuticals Corporation. v. [read post]
9 Jun 2022, 4:03 am by Linda O'Brien (CCH)
Thus, the Board’s decision that the challenged claims of the patent were unpatentable was affirmed (Ethicon LLC v. [read post]
Swan€ 112 Chinese Patent Law: A Practical Guide by Sun Changlong, Zhang Junjie, Fanwen Kong, Dang Li, Yongbo Li, Zhang Liang (William), Wang Meng, Zhang Qiulin, Wang Rong, Gu Runfeng, Chen Shasha, Lu Weiting, Ge Xiaomei, Yang Yang, He Yibo€ 148 [read post]
A dissenting judge argued that one of the patents contained plausibly valid claims that recited technical improvements to a graphical user interface (International Business Machines Corp. v. [read post]